Latest by Sony Salzman
Exploring the Possible Dangers of HIV and Zika Coinfection Among Pregnant Women and Newborn Children
In response to the Zika epidemic, the National Institutes for Health (NIH) has launched a study to shed light on how coinfection with HIV and Zika impact maternal and fetal health.
HIV-Positive Trans Women Worry About Side Effects of Taking Hormone Therapy and HIV Treatment Together
Many trans women worry about the harmful side effects of taking hormone therapy and antiretroviral therapy at the same time, prompting some to stop treatment.
Over the past decade, the District of Columbia has seen more than a 74% decrease in the number of new HIV infections, from 1,333 new cases in 2007 to 347 in 2016. What's behind this decrease?
The medical community may have dramatically underestimated the power of the vaginal microbiome -- a biological factor that could make or break the effectiveness of PrEP and vaccine research efforts.
The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become ava...
For the small percentage of HIV patients struggling with drug resistance, an expanded access program for a new injectable treatment might be the answer.
New hepatitis C treatments are changing the equation for people coinfected with HIV and hep C: shorter treatment times, reduced side effects and sky-high cure rates.
Could I Be Turned Down for Hepatitis C Treatment Because of Prior Drug or Alcohol Use? A Doctor Explains
There is no information to support the idea that substance users have higher reinfection rates than non-users, explains Dr. Maribel Rodriguez-Torres. who says she would never refuse such a patient unless I thought he was truly unable to stay complian...
"Prioritization is usually determined based on a patient's level of cirrhosis, or liver scarring," explains Maribel Rodriguez-Torres, M.D., a leader in hepatitis C research and treatment in Puerto Rico.
¿Por qué dirían los médicos que alguien debe esperar hasta que su condición empeore para recibir tratamiento? Un líder en la investigación y tratamiento de la hepatitis C ayuda a clarificar esta pregunta importante.